Reading SRPT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track SRPT free→Reading SRPT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track SRPT free→QuarterlyIQ Insights · SRPT
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
The filing describes the approval of equity incentive and stock purchase plans, not a management change.
of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 25, 2026, Douglas Ingram notified Sarepta Therapeutics, Inc. (the “Company”) of his decision to retire as Chief Executive Officer by the end of 2026 or upon the appointment of his replacement. The Company has commenced a search of internal and external candidates for Mr. Ingram’s replacement. SIGNATURES Pursuant to the requirements of t…
Importance-ranked changes since the prior daily snapshot.
Valuation fell by 10.6 points (from 82.2 to 71.6).
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.